PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
A Prospective Cohort Study Assessing the Efficacy and Safety of Tarceva in 2nd Line in Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
1 other identifier
observational
152
1 country
110
Brief Summary
This observational study will evaluate the efficacy and safety of Tarceva (erlotinib) in second line in patients with locally advanced or metastatic squamous non-small cell lung cancer (NSCLC) after failure of first line platinum-based chemotherapy. Eligible patients will be followed for 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2012
110 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 6, 2012
CompletedFirst Posted
Study publicly available on registry
August 8, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedNovember 2, 2016
November 1, 2016
1.8 years
August 6, 2012
November 1, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Progression-free survival
2 years
Secondary Outcomes (5)
Clinical/demographic patients characteristics at baseline
2 years
Treatment schedules: Dose/duration/modifications/interruptions
2 years
Overall survival
2 years
Safety: Incidence of adverse events
2 years
Quality of life: FACT-L version 4 questionnaire
2 years
Study Arms (1)
Cohort
Eligibility Criteria
Patients with locally advanced or metastatic squamous NSCLC initiating 2nd line treatment with Tarceva
You may qualify if:
- Adult patients, \>/= 18 years of age
- Histologically or cytologically confirmed advanced (Stage IIIB) or metastatic (Stage IV) squamous non-small cell lung cancer after failure of first-line platinum-based chemotherapy
- Patients for whom the treating physician has decided to initiate treatment with Tarceva
You may not qualify if:
- Mixed non-small cell and small-cell lung carcinoma or mixed squamous cell carcinoma with predominant adenocarcinoma component
- Current participation in a clinical trial evaluating an anticancer treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (110)
Unknown Facility
Abbeville, 80142, France
Unknown Facility
Agen, 47000, France
Unknown Facility
Aix-en-Provence, 13616, France
Unknown Facility
Aix-en-Provence, 13617, France
Unknown Facility
Amiens, 80090, France
Unknown Facility
Angers, 49933, France
Unknown Facility
Antibes, 06600, France
Unknown Facility
Armentières, 59421, France
Unknown Facility
Aulnay-sous-Bois, 93602, France
Unknown Facility
Bar-le-Duc, 55012, France
Unknown Facility
Bayonne, 64100, France
Unknown Facility
Beuvry, 62660, France
Unknown Facility
Bordeaux, 33000, France
Unknown Facility
Boulogne-Billancourt, 92100, France
Unknown Facility
Bourg-en-Bresse, 01012, France
Unknown Facility
Brive-la-Gaillarde, 19312, France
Unknown Facility
Bron, 69677, France
Unknown Facility
Bry-sur-Marne, 94366, France
Unknown Facility
Carcassonne, 11890, France
Unknown Facility
Castres, 81108, France
Unknown Facility
Chalon-sur-Saône, 71100, France
Unknown Facility
Chambéry, 73011, France
Unknown Facility
Charleville-Mézières, 08011, France
Unknown Facility
Chaumont, 52014, France
Unknown Facility
Chauny, 02303, France
Unknown Facility
Clamart, 92141, France
Unknown Facility
Clermont-Ferrand, 63003, France
Unknown Facility
Colmar, 68024, France
Unknown Facility
Compiègne, 60321, France
Unknown Facility
Créteil, 94010, France
Unknown Facility
Dijon, 21000, France
Unknown Facility
Dijon, 21079, France
Unknown Facility
Draguignan, 83007, France
Unknown Facility
Dunkirk, 59240, France
Unknown Facility
Ermont, 95120, France
Unknown Facility
Épernay, 51205, France
Unknown Facility
Férolles-Attilly, 77150, France
Unknown Facility
Forbach, 57604, France
Unknown Facility
Gap, 05007, France
Unknown Facility
Gleizé, 69400, France
Unknown Facility
Gonesse, 95503, France
Unknown Facility
La Rochelle, 17019, France
Unknown Facility
La Source, 45100, France
Unknown Facility
La Tronche, 38700, France
Unknown Facility
Lagny-sur-Marne, 77405, France
Unknown Facility
Le Mans, 72015, France
Unknown Facility
Le Mans, 72037, France
Unknown Facility
Le Puy-en-Velay, 43012, France
Unknown Facility
Lille, 59000, France
Unknown Facility
Lille, 59037, France
Unknown Facility
Lille, 59042, France
Unknown Facility
Limoges, 87042, France
Unknown Facility
Lisieux, 14107, France
Unknown Facility
Longjumeau, 91161, France
Unknown Facility
Lorient, 56322, France
Unknown Facility
Lyon, 69275, France
Unknown Facility
Lyon, 69365, France
Unknown Facility
Manosque, 04101, France
Unknown Facility
Mantes-la-Jolie, 78200, France
Unknown Facility
Mareuil-lès-Meaux, 77100, France
Unknown Facility
Marseille, 13291, France
Unknown Facility
Meaux, 77104, France
Unknown Facility
Metz, 57038, France
Unknown Facility
Metz-Tessy, 74370, France
Unknown Facility
Mont-de-Marsan, 40024, France
Unknown Facility
Montpellier, 34070, France
Unknown Facility
Nancy, 54100, France
Unknown Facility
Nantes, 44202, France
Unknown Facility
Narbonne, 11780, France
Unknown Facility
Neuilly-sur-Seine, 92200, France
Unknown Facility
Paris, 75231, France
Unknown Facility
Paris, 75475, France
Unknown Facility
Paris, 75908, France
Unknown Facility
Paris, 75970, France
Unknown Facility
Perpignan, 66000, France
Unknown Facility
Perpignan, 66046, France
Unknown Facility
Pierre-Bénite, 69495, France
Unknown Facility
Poitiers, 86021, France
Unknown Facility
Pontoise, 95300, France
Unknown Facility
Quimper, 29000, France
Unknown Facility
Rambouillet, 78514, France
Unknown Facility
Reims, 51056, France
Unknown Facility
Reims, 51100, France
Unknown Facility
Rennes, 35033, France
Unknown Facility
Rouen, 76000, France
Unknown Facility
Rouen, 76031, France
Unknown Facility
Saint-Dié, 88187, France
Unknown Facility
Saint-Dizier, 52115, France
Unknown Facility
Saint-Jean, 31240, France
Unknown Facility
Saint-Laurent-du-Var, 06700, France
Unknown Facility
Saint-Omer, 62500, France
Unknown Facility
Saint-Priest-en-Jarez, 42271, France
Unknown Facility
Saint-Priest-en-Jarez, 42770, France
Unknown Facility
Saint-Quentin, 02321, France
Unknown Facility
Saintes, 17108, France
Unknown Facility
Strasbourg, 67000, France
Unknown Facility
Strasbourg, 67010, France
Unknown Facility
Strasbourg, 67065, France
Unknown Facility
Strasbourg, 67091, France
Unknown Facility
Thionville, 57126, France
Unknown Facility
Thonon-les-Bains, 74203, France
Unknown Facility
Toulon, 83041, France
Unknown Facility
Toulon, 83056, France
Unknown Facility
Toulouse, 31076, France
Unknown Facility
Tours, 37000, France
Unknown Facility
Valence, 26000, France
Unknown Facility
Vandœuvre-lès-Nancy, 54511, France
Unknown Facility
Vannes, 56017, France
Unknown Facility
Verdun, 55107, France
Unknown Facility
Vénissieux, 69200, France
Study Officials
- STUDY DIRECTOR
Clinical Trials
Hoffmann-La Roche
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2012
First Posted
August 8, 2012
Study Start
June 1, 2012
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
November 2, 2016
Record last verified: 2016-11